Filing Details
- Accession Number:
- 0001209191-16-138385
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-08-23 18:16:25
- Reporting Period:
- 2016-08-19
- Filing Date:
- 2016-08-23
- Accepted Time:
- 2016-08-23 18:16:25
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 949858 | Oncogenex Pharmaceuticals Inc. | OGXI | In Vitro & In Vivo Diagnostic Substances (2835) | 954343413 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1477056 | John Bencich | 19820 North Creek Parkway Suite 201 Bothell WA 98011 | Cfo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-08-19 | 5,000 | $0.00 | 5,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-08-19 | 1,380 | $0.57 | 9,484 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Unit (RSU) | Disposition | 2016-08-19 | 5,000 | $0.00 | 5,000 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 10,000 | No | 4 | M | Direct |
Footnotes
- Represents shares of common stock acquired upon settlement of the restricted stock units ("RSUs") listed in Table II.
- Represents shares of common stock that have been sold by the issuer to satisfy the tax liability in connection with the settlement of RSUs.
- Each restricted stock unit (RSU) represents a contingent right to receive one share of the issuer's common stock at settlement.
- Pursuant to the terms of the RSU, 25% of the total shares underlying the RSU vest annually on the later of: (i) each anniversary of August 12, 2014 and (ii) the first day thereafter during which the issuer's trading window is open.
- The RSUs expire 30 days from the date they vest.
Billionaire Hedge Funds
